Organization
Hopital Universitaire de Bruxelles (HUB)
1 abstract
Abstract
Avelumab (A) as neoadjuvant therapy in patients (pts) with muscle-invasive urothelial carcinoma (MIUC): Survival data of AURA trial, Oncodistinct 004.Org: Centre Hospitalier Universitaire de Ambrois Paré, Hôpital Paris Saint-Joseph, University Hospital of Liège, CHU Sart-Tilman, Institut Roi Albert II,